Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
CARDIOLOGY / CLINICAL RESEARCH
Risk factors of incomplete endothelialization after left atrial appendage occlusion in patients with atrial fibrillation
1
Department of Cardiology, the Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China
2
Dalian Medical University, Dalian, China
Submission date: 2023-09-16
Final revision date: 2024-04-14
Acceptance date: 2024-05-09
Online publication date: 2024-06-07
Publication date: 2025-02-28
Corresponding author
Zhong-Bao Ruan
MD, FACC Department of Cardiology the affiliated Taizhou People’s Hospital of Nanjing Medical University Taizhou School of Clinical Medicine Nanjing Medical University Taizhou 225300, China Phone: +8613401238518
MD, FACC Department of Cardiology the affiliated Taizhou People’s Hospital of Nanjing Medical University Taizhou School of Clinical Medicine Nanjing Medical University Taizhou 225300, China Phone: +8613401238518
Arch Med Sci 2025;21(1):75-83
KEYWORDS
TOPICS
ABSTRACT
Introduction:
We aimed to investigate the risk factors of incomplete device endothelialization (IDE) following left atrial appendage occlusion (LAAO) and provide a nomogram model for predicting the risks of IDE in patients with atrial fibrillation (AF).
Material and methods:
A total of 145 patients with AF who underwent LAAO were included. The endothelialization of the occluder was assessed by computed tomography angiography (CTA) at 3 months after LAAO. Logistic regression analysis was used to explore the risk factors of IDE after LAAO. A nomogram model was constructed to predict the risks of IDE.
Results:
53 cases with complete endothelialization (CDE group) and 92 cases with IDE (IDE group) were detected at 3 months after LAAO. There was a significant difference in mitral regurgitation (MR) (37.7% vs. 55.4%, p = 0.040), left atrial appendage (LAA) diameter ((2.22 ±0.36) cm vs. (2.61± 2.11) cm, p = 0.003), occluder size ((2.76 ±0.36) cm vs. (2.93 ±0.34) cm, p = 0.005) and the level of serum urea ((5.78 ±1.72) mmol/l vs. (6.67 ±2.82) mmol/l, p = 0.020) between the two groups. Serum urea level, MR, LAA diameter and large occluder size were independent risk factors for IDE (p = 0.038, 0.041, 0.007 and 0.006, respectively). A nomogram prediction model based on MR, LAA diameter, occluder size and serum urea was constructed with a C-index of 0.70, while the C-index of verification was 0.708.
Conclusions:
MR, higher serum urea level, LAA diameter and large occluder size may contribute to IDE after LAAO. The nomogram model based on MR, LAA diameter, occluder size and serum urea can be used to predict the IDE after LAAO.
We aimed to investigate the risk factors of incomplete device endothelialization (IDE) following left atrial appendage occlusion (LAAO) and provide a nomogram model for predicting the risks of IDE in patients with atrial fibrillation (AF).
Material and methods:
A total of 145 patients with AF who underwent LAAO were included. The endothelialization of the occluder was assessed by computed tomography angiography (CTA) at 3 months after LAAO. Logistic regression analysis was used to explore the risk factors of IDE after LAAO. A nomogram model was constructed to predict the risks of IDE.
Results:
53 cases with complete endothelialization (CDE group) and 92 cases with IDE (IDE group) were detected at 3 months after LAAO. There was a significant difference in mitral regurgitation (MR) (37.7% vs. 55.4%, p = 0.040), left atrial appendage (LAA) diameter ((2.22 ±0.36) cm vs. (2.61± 2.11) cm, p = 0.003), occluder size ((2.76 ±0.36) cm vs. (2.93 ±0.34) cm, p = 0.005) and the level of serum urea ((5.78 ±1.72) mmol/l vs. (6.67 ±2.82) mmol/l, p = 0.020) between the two groups. Serum urea level, MR, LAA diameter and large occluder size were independent risk factors for IDE (p = 0.038, 0.041, 0.007 and 0.006, respectively). A nomogram prediction model based on MR, LAA diameter, occluder size and serum urea was constructed with a C-index of 0.70, while the C-index of verification was 0.708.
Conclusions:
MR, higher serum urea level, LAA diameter and large occluder size may contribute to IDE after LAAO. The nomogram model based on MR, LAA diameter, occluder size and serum urea can be used to predict the IDE after LAAO.
REFERENCES (30)
1.
Kapur S, Mansour M. Left atrial appendage closure devices for stroke prevention. Arrhythm Electrophysiol Rev 2014; 3: 25-9.
2.
Gawałko M, Budnik M, Uziębło-Życzkowska B, et al. Risk of left atrial appendage thrombus in older patients with atrial fibrillation. Arch Med Sci 2021; 19: 1721-30.
3.
Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996; 61: 755-9.
4.
Lind A, Azizy O, Lortz J, Janosi A, Rassaf T, Rammos C. Percutaneous left atrial appendage closure for stroke prevention in patients with chronic renal disease. Arch Med Sci 2020; 19: 331-6.
5.
Gilhofer TS, Nestelberger T, Kang M, et al. Stroke prevention with left atrial appendage closure in patients with atrial fibrillation and prior intracranial hemorrhage. CJC Open 2023; 5: 404-11.
6.
Reddy VY, Doshi SK, Kar S, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol 2017; 70: 2964-75.
7.
Holmes DR Jr, Reddy VY, Gordon NT, et al. Long-term safety and efficacy in continued access left atrial appendage closure registries. J Am Coll Cardiol 2019; 74: 2878-89.
8.
Schwartz RS, Holmes DR, Van Tassel RA, et al. Left atrial appendage obliteration: mechanisms of healing and intracardiac integration. JACC Cardiovasc Interv 2010; 3: 870-7.
9.
Lammers J, Elenbaas T, Meijer A. Thrombus formation on an Amplatzer closure device after left atrial appendage closure. Eur Heart J 2013; 34: 741.
10.
Sinanis T. A very late and persistent thrombosis after left atrial appendage occlusion. Heart Views 2019; 20: 175-7.
11.
Prosperi-Porta G, Schnell G, Colbert J, Franko A, Wilton SB, Kuriachan VP. Multiple. thromboembolic vents from a left atrial appendage occlusion device. Can J Cardiol 2018; 34: 342. e13-342.e15.
12.
Sharma SP, Singh D, Nakamura D, Gopinathannair R, Lakkireddy D. Incomplete endothelialization of WatchmanTM Device: predictors and Implications from two cases. J Atr Fibrillation 2019; 11: 2162.
13.
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42: 373-498.
14.
Ruan ZB, Wang F, Chen GC, Zhu L. A comparative study of three imaging modalities for size selection of a Watchman left atrial appendage closure device. Yonsei Med J 2022; 63: 325-32.
15.
Li W, Gao R, Zhao J, et al. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion. Ann Palliat Med 2022; 11: 201-9.
16.
Saw J, Fahmy P, DeJong P, et al. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure. Eur Heart J Cardiovasc Imaging 2015; 16: 1198-206.
17.
Angelillis M, Gargiulo G, Moschovitis A, et al. Computed tomography detection and quantification of left atrial appendage residual patency as collateral finding after percutaneous closure. Int J Cardiol 2018; 260: 42-6.
18.
Saw J, Lopes JP, Reisman M, McLaughlin P, Nicolau S, Bezerra HG. Cardiac computed tomography angiography for left atrial appendage closure. Canad J Cardiol 2016; 32: 1033.e1-9.
19.
Agudelo VH, Millán X, Li CH, et al. Prevalence, mechanisms and impact of residual patency and device-related thrombosis following left atrial appendage occlusion: a computed tomography analysis. EuroIntervention 2021; 17: e944-52.
20.
Kar S, Hou D, Jones R, et al. Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model. JACC Cardiovasc Interv 2014; 7: 801-9.
21.
Sinno H, Prakash S. Complements and the wound healing cascade: an updated review. Plast Surg Int 2013; 2013: 146764.
23.
Reinthaler M, Grosshauser J, Schmidt T, et al. Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model. Sci Rep 2021; 11: 2988.
24.
Freixa X, Cepas-Guillen P, Flores-Umanzor E, et al. Pulmonary ridge coverage and device-related thrombosis after left atrial appendage occlusion. EuroIntervention 2021; 16: e1288-94.
25.
Xu J, Chen CZ, Xing J, et al. Clinical relevance of incomplete device endothelialization after left atrial appendage closure. Int J Cardiovasc Imaging 2023; 39: 451-9.
26.
Granier M, Laugaudin G, Massin F, et al. Occurrence of incomplete endothelialization causing residual permeability after left atrial appendage closure. J Invasive Cardiol 2018; 30: 245-50.
27.
Lindenfeld J, Schrier RW. Blood urea nitrogen a marker for adverse effects of loop diuretics? J Am Coll Cardiol 2011; 58: 383-5.
28.
Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z. Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus. Kidney Int 2018; 93: 741-52.
29.
KiJker IH. Blood urea nitrogen increase is an expected finding in nonvariceal upper GI bleeding patients with underlying moderate or severe renal disease. Gastrointest Endose 2018; 87: 1366.
30.
Shen G, Huang JY, Yu YL, et al. J-shaped association between serum uric acid and acute coronary syndrome in patients with essential hypertension. Postgraduate Med J 2020; 96: 73-8.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
